Print page content Print
Increase text size Decrease text size
Text Size



A convenient once - daily oral fluoroquinolone antibacterial for cats and dogs


ZENIQUIN (marbofloxacin) tablets are indicated for the treatment of skin and soft-tissue infections in dogs and cats and urinary tract infections in dogs with bacteria susceptible to marbofloxacin.

ZENIQUIN has the highest known tissue concentrations in the skin, kidney and lung compared with other veterinary-approved fluoroquinolones at the lowest recommended dose .1,2

Collapse All
    • ZENIQUIN has the highest area under the curve (AUC) compared with all other veterinary-approved fluoroquinolones.1,3-6
    • ZENIQUIN has a longer half-life than any other veterinary-approved fluoroquinolone.1,4-6
    • Target animal safety studies in cats did not demonstrate inducible dose-related ocular toxicity.
    • Convenient once-a-day dosing.
    • Scored and film-coated tablets are available in 4 sizes, providing flexible dosing for small to giant-sized breeds.

    Please refer to the full prescribing information for more dosage and administration information.

  • 1. ZENIQUIN US Prescribing Information. NADA #141-151. Zoetis Inc, 2001.
    2. Sheer M. Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril. Vet Med Rev. 1987;2:104-118.
    3. Blaser J, et al. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother. 1987;31:1054-1060.
    4. Stegmann M, et al. Kinetics of antibacterial activity after administration of enrofloxacin in dog serum and skin: in vitro susceptibility of field isolates. In Proceedings. 2nd International Veterinary Symposium of Fluoroquinolones. Compend Contin Educ Pract Vet. 1996;18(suppl):30-34.
    5. Dicural® US Prescribing Information. NADA #141-096. Overland Park, KS: Fort Dodge Animal Health, 1997.
    6. Orbax® US Prescribing Information. NADA #141-081. Union, NJ: Schering-Plough Animal Health Corporation, 1997.

IMPORTANT SAFETY INFORMATION: Important Safety Information: ZENIQUIN is not recommended for use in immature cats or dogs during the rapid growth phase, or in cats or dogs known to be hypersensitive to fluoroquinolones. People with a history of hypersensitivity to fluoroquinolones should avoid this product.

For more safety information, refer to the full prescribing information.



We are Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2021 Zoetis Services LLC. All rights reserved.